Szymon Parzych

Szymon Parzych

Auto-generated profile, based on publicly available information

Szymon Parzych

Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, Kraków, Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 January 2026 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Verified
Journal Article
Open access
KDKamil Dulski
Kamil Dulski
EBE. Beyene
E. Beyene
NCN. Chug
N. Chug
CCCatalina Curceanu
Catalina Curceanu
ECEryk Czerwiński
Eryk Czerwiński
PMPawel Moskal
Pawel Moskal

6 June 2026 in Physics Letters B
Verified
Journal Article
Open access
SSSushil Sharma
Sushil Sharma
KDKamil Dulski
Kamil Dulski
EBErmias Yitayew Beyene
Ermias Yitayew Beyene
NCN. Chug
N. Chug
CCCatalina Curceanu
Catalina Curceanu
PMPawel Moskal
Pawel Moskal

3 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
PMPawel Moskal
Pawel Moskal
JBJ. Baran
J. Baran
SBSteven D. Bass
Steven D. Bass
JCJarosław Choiński
Jarosław Choiński
NCN. Chug
N. Chug
Ewa Łucja StępieńEwa Łucja Stępień
Ewa Łucja Stępień
Positronium, an unstable atom consisting of an electron and a positron, is abundantly produced within the molecular voids of a patient’s body during positron emission tomography (PET) diagnosis. Its properties, such as its average lifetime between formation and annihilation into photons, dynamically respond to the submolecular architecture of the tissue and the partial pressure of oxygen molecules. However, the diagnostic information that positronium may deliver about early molecular alterations remains unavailable in clinics with state-of-the-art PET scanners. This study presents the first in vivo images of positronium lifetime in humans. We developed a dedicated J-PET system with multiphoton detection capability for imaging. The measurements of positronium lifetime were performed on a patient with a glioblastoma tumor in the brain. The patient was injected intratumorally with the 68 Ga radionuclide attached to Substance-P, which accumulates in glioma cells, and intravenously with 68 Ga attached to the PSMA-11 ligand, which is selective to glioma cells and salivary glands. The 68 Ga radionuclide is routinely used in PET for detecting radiopharmaceutical accumulation and was applied for positronium imaging because it can emit an additional prompt gamma. The prompt gamma enables the determination of the time of positronium formation, while the photons from positronium annihilation were used to reconstruct the place and time of its decay. The determined positronium mean lifetime in glioblastoma cells is shorter than in salivary glands, which in turn is shorter than in healthy brain tissues, demonstrating for the first time that positronium imaging can be used to diagnose disease in vivo . This study also demonstrates that if current total-body PET systems were equipped with multiphoton detection capability and the 44 Sc radionuclide was applied, it would be possible to perform positronium imaging at 6500 times greater sensitivity than achieved in this research. Therefore, it is anticipated that positronium imaging has the potential to bring a new quality of cancer diagnosis in clinics.

19 July 2026 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
SPSzymon Parzych
Szymon Parzych
SNSzymon Niedźwiecki
Szymon Niedźwiecki
EBErmias Yitayew Beyene
Ermias Yitayew Beyene
NCNeha Chug
Neha Chug
MCMaurizio Conti
Maurizio Conti
PMPaweł Moskal
Paweł Moskal
Background: After its first ex-vivo and in-vivo demonstration, Positronium Lifetime Imaging (PLI) has received considerable interest as a potential new diagnostic biomarker. High sensitivity Positron Emission Tomography (PET) systems are needed for PLI since it requires simultaneous registration of annihilation photons and prompt gamma. In this simulation-based study, a feasibility of PLI with the long axial field-of-view Biograph Vision Quadra (Quadra) and the Total Body J-PET scanner was investigated. Methods: The study was performed using the GATE software. Background radiation, present within the Quadra tomograph, was added to the simulation. First, the optimal placement of the energy window for the registration of the prompt gamma was investigated. Next, the organ-wise sensitivity of Quadra was calculated for the $$^{68}$$ Ga, $$^{44}$$ Sc, $$^{22}$$ Na and $$^{124}$$ I radioisotopes. Finally, the sensitivity for the scandium isotope was compared to the sensitivities obtainable with the Total Body J-PET scanner, as well as with the modular J-PET prototype. Results: The PLI sensitivities for the Quadra with the background radiation are estimated to 9.22(3), 10.46(4), 5.91(3), and 15.39(4) cps/kBq for the $$^{44}$$ Sc, $$^{68}$$ Ga, $$^{22}$$ Na and $$^{124}$$ I radioisotopes, respectively. The highest sensitivity was obtained when the energy window for the deexcitation photon is adjacent to the energy window for the annihilation photons. In case of J-PET, the sensitivities for the $$^{44}$$ Sc were estimated to 0.062(08) and 1.714(40) cps/kBq for the modular and Total Body J-PET scanners, respectively. The determined PLI sensitivities with Quadra and the Total Body J-PET are in the order of sensitivities of metabolic PET imaging with the short axial field-of-view ( $$\sim $$ 20 cm) PET scanners based on pure positron emitter isotopes. Conclusions: The PLI sensitivity of Quadra has been computed for the $$^{68}$$ Ga, $$^{44}$$ Sc, $$^{22}$$ Na and $$^{124}$$ I radioisotopes. A sensitivity gain by a factor of 150 was estimated relative to the modular J-PET system previously used for the first in-vivo PLI. Additionally, the sensitivity for Total Body J-PET is expected to be about 30 times higher than for modular J-PET.